Although executives said the US launch of its Novum IQ large volume pump was going well, there were “recurring life-threatening defects in the devices that Baxter could not adequately correct” and failed to disclose to investors, a pension fund asserted in a complaint filed Thursday in the US District Court for the Northern District of Illinois.
The fund seeks to represent a class of investors who acquired Baxter stock ...